Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $156.19
-
Support level$145.44
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)56.9
- GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $117.88 | $157.37 | 97.4% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $138.03 | $146.84 | $149.97 | $149.94 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.2%
-
In the next month14.6%
-
In the next year51.2%
| Period | Value |
|---|---|
| Historical (5 year) | 24.5% |
| Last month | 26.1% |
| Current estimate | 26.6% |
| Next month forecast | 25.7% |